Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature 429, 834-840 (24 June 2004) | doi:10.1038/nature02592; Received 8 March 2004; Accepted 21 April 2004
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
nature jobs
Developer - Variation (Bioinformatician)
- European Bioinformatics Institute (EBI)
- Cambridge CB10 1SD United Kingdom
Biochemical Pharmacologist
- Eisai London Research Laboratories Ltd
- Hatfield, United Kingdom
A membrane protein required for dislocation of misfolded proteins from the ER
Brendan N. Lilley1 & Hidde L. Ploegh1
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, 02115, USA
Correspondence to: Hidde L. Ploegh1 Email: ploegh@hms.harvard.edu
Abstract
After insertion into the endoplasmic reticulum (ER), proteins that fail to fold there are destroyed. Through a process termed dislocation such misfolded proteins arrive in the cytosol, where ubiquitination, deglycosylation and finally proteasomal proteolysis dispense with the unwanted polypeptides. The machinery involved in the extraction of misfolded proteins from the ER is poorly defined. The human cytomegalovirus-encoded glycoproteins US2 and US11 catalyse the dislocation of class I major histocompatibility complex (MHC) products, resulting in their rapid degradation. Here we show that US11 uses its transmembrane domain to recruit class I MHC products to a human homologue of yeast Der1p, a protein essential for the degradation of a subset of misfolded ER proteins. We show that this protein, Derlin-1, is essential for the degradation of class I MHC molecules catalysed by US11, but not by US2. We conclude that Derlin-1 is an important factor for the extraction of certain aberrantly folded proteins from the mammalian ER.
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, 02115, USA
Correspondence to: Hidde L. Ploegh1 Email: ploegh@hms.harvard.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Research HighlightsNature Structural & Molecular Biology News and Views (01 Mar 2006)
Lectins sweet-talk proteins into ERADNature Cell Biology News and Views (01 Mar 2008)
See all 6 matches for News And ViewsRESEARCH
A point mutation in CD28 distinguishes proliferative signals from survival signalsNature Immunology Article (01 Apr 2001)
Langerhans Cells Integrated into Human Reconstructed Epidermis Respond to Known Sensitizers and Ultraviolet ExposureJournal of Investigative Dermatology Letter
See all 46 matches for Research
